New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 13, 2018 - Perrigo has discontinued scopolamine transdermal system due to business reasons.
Download PDF
Return to publications
